breast cancer

News

Radiology technician examens mammography test on location

NICE backs two new breast cancer drugs for NHS use

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

News

Lilly's Verzenios gets NICE blessing for early-stage breast ...

Thousands more people with breast cancer in England look set to be eligible for routine treatment with Eli Lilly's Verzenios, after new guidance from NICE backed use of the drug after surge

News

Lilly partners with Sidekick in digital health alliance

A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from a newly-announced partnership between digital health specialist Sidekick an

Oncology

Redefining the approach to cancer care – a mission to improv...

Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million deaths, making cancer the

News

ASCO22: Gilead makes case for Trodelvy in advanced breast ca...

In March, Gilead Sciences reported positive results for its TROPiCS-02 study of Trodelvy, but the guarded tone of the announcement led to speculation that the data was not as strong as hope

News